Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Fungal infections are common in severe COVID-19 cases but their impact on disease severity is unclear.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

A variant in the ADAM17 gene causes hair loss by increasing protein degradation through TRIM47.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

COVID-19 pneumonia requires more intensive care, including monitoring liver functions and DVT, due to higher D-dimer and procalcitonin levels.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.

Long COVID affects about 27% of patients, with higher risk for women, lower education, and certain income levels.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Post-COVID-19 patients are at risk for hair loss.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

About 61% of women who had COVID-19 experienced hair loss afterward.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Many people in Central India have long-term health issues after COVID-19, highlighting the need for prevention and support programs.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

Long COVID causes lasting health issues, needing ongoing research and better healthcare strategies.

COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

The Pfizer COVID-19 vaccine may rarely trigger nail psoriasis.

Children may have lingering respiratory issues after recovering from COVID-19.

Ninjin'yoeito, a Japanese medicine, helped stop hair loss and improved mood in two post-COVID-19 patients.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

COVID-19 may harm male fertility and damage the reproductive system.